Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1989 1
1990 2
1991 1
1992 1
1993 1
1994 1
1995 3
1996 1
1997 1
1999 1
2002 2
2005 3
2006 1
2009 2
2010 3
2011 5
2012 3
2013 1
2014 2
2015 4
2016 1
2018 4
2019 3
2020 5
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers.
Bill R, Wirapati P, Messemaker M, Roh W, Zitti B, Duval F, Kiss M, Park JC, Saal TM, Hoelzl J, Tarussio D, Benedetti F, Tissot S, Kandalaft L, Varrone M, Ciriello G, McKee TA, Monnier Y, Mermod M, Blaum EM, Gushterova I, Gonye ALK, Hacohen N, Getz G, Mempel TR, Klein AM, Weissleder R, Faquin WC, Sadow PM, Lin D, Pai SI, Sade-Feldman M, Pittet MJ. Bill R, et al. Among authors: mckee ta. Science. 2023 Aug 4;381(6657):515-524. doi: 10.1126/science.ade2292. Epub 2023 Aug 3. Science. 2023. PMID: 37535729 Free PMC article.
Response of NF1-Mutated Melanoma to an MEK Inhibitor.
Py C, Christinat Y, Kreutzfeldt M, McKee TA, Dietrich PY, Tsantoulis P. Py C, et al. Among authors: mckee ta. JCO Precis Oncol. 2018 Nov;2:1-11. doi: 10.1200/PO.18.00028. JCO Precis Oncol. 2018. PMID: 35135154 No abstract available.
[Molecular pathology--an overview].
McKee TA. McKee TA. Rev Med Suisse. 2005 Nov 30;1(43):2786-8, 2790. Rev Med Suisse. 2005. PMID: 16396367 French.
Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma.
Christinat Y, Ho L, Clément S, Genestie C, Sehouli J, Cinieri S, Gonzalez Martin A, Denison U, Fujiwara K, Vergote I, Tognon G, Hietanen S, Ray-Coquard I, Pujade-Lauraine E, McKee TA. Christinat Y, et al. Among authors: mckee ta. JCO Precis Oncol. 2023 Jun;7:e2200555. doi: 10.1200/PO.22.00555. JCO Precis Oncol. 2023. PMID: 37364234 Free PMC article.
Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.
Zoetemelk M, Ramzy GM, Rausch M, Koessler T, van Beijnum JR, Weiss A, Mieville V, Piersma SR, de Haas RR, Delucinge-Vivier C, Andres A, Toso C, Henneman AA, Ragusa S, Petrova TV, Docquier M, McKee TA, Jimenez CR, Daali Y, Griffioen AW, Rubbia-Brandt L, Dietrich PY, Nowak-Sliwinska P. Zoetemelk M, et al. Among authors: mckee ta. Mol Oncol. 2020 Nov;14(11):2894-2919. doi: 10.1002/1878-0261.12797. Epub 2020 Oct 5. Mol Oncol. 2020. PMID: 33021054 Free PMC article.
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss.
Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P. Frisone D, et al. Among authors: mckee ta. Cancer Biol Ther. 2020;21(3):197-202. doi: 10.1080/15384047.2019.1685291. Epub 2019 Nov 10. Cancer Biol Ther. 2020. PMID: 31709901 Free PMC article.
54 results